{"id":69022,"date":"2026-03-13T12:06:16","date_gmt":"2026-03-13T12:06:16","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69022"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"igf-1-lr3","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/igf-1-lr3\/","title":{"rendered":"IGF-1 LR3"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es IGF-1 LR3?<\/h3>\n<p style=\"margin: 0;\"><strong>IGF-1 LR3<\/strong> is a peptide supplied as a lyophilized powder for reconstitution. The information on this page describes published preclinical and early clinical literature; it is not medical advice or dosing guidance. Read our linked guide for the complete evidence summary.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<h2 data-section-id=\"1v2vk1x\">P\u00e9ptido IGF-1 LR3<\/h2>\n<p><span style=\"font-size: 120%;\">IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of insulin-like growth factor-1 designed for studies involving cellular growth signaling, anabolic pathways, and metabolic regulation. This extended variant contains structural modifications that increase its stability and prolong its biological activity compared to standard IGF-1, allowing users to study sustained IGF-1 receptor activation in clinical models. IGF-1 LR3 interacts with IGF-1 receptors involved in cellular proliferation, protein synthesis, and nutrient utilization. Due to its extended half-life and reduced binding to IGF-binding proteins, it provides a useful framework for examining mechanisms related to tissue growth, metabolic efficiency, and cellular repair processes. Studies suggest IGF-1 LR3 may support pathways associated with muscle cell growth, enhanced protein synthesis, improved recovery from physical stress, and regulation of glucose metabolism. Its activity also makes it valuable for investigating regenerative signaling, cellular differentiation, and anabolic responses in controlled experimental environments.<\/span><\/p>\n<hr \/>\n<h2 data-section-id=\"1bovg99\"><strong>Descripci\u00f3n del producto<\/strong><\/h2>\n<p>IGF-1 LR3 is a synthetic peptide classified as a modified insulin-like growth factor analog engineered to extend biological stability and receptor interaction duration in clinical models. With the molecular formula C400H625N111O115S9 and molar mass of 9117.60 g\/mol, IGF-1 LR3 peptide is widely studied in experimental clinical settings focusing on cellular growth pathways and metabolic signaling. Each vial contains 0.1 mg or 1 mg of lyophilized IGF-1 LR3 supplied in high purity lyophilized form designed for clinical investigation. The peptide is valued for its structural modifications that reduce binding to IGF-binding proteins and prolong receptor activity in controlled studies environments. <\/p>\n<hr \/>\n<h2 data-section-id=\"engqt1\"><strong>Published Evidence<\/strong><\/h2>\n<p>IGF-1 LR3 peptide is commonly utilized in clinical investigation of cellular growth signaling and anabolic pathway activity. In vitro studies frequently examine IGF-1 receptor activation and downstream intracellular signaling mechanisms associated with protein synthesis and nutrient utilization. Pre-clinical models use IGF-1 LR3 for studies to analyze cellular proliferation patterns and metabolic regulation responses. Users also explore tissue culture environments where growth factor signaling can be measured under controlled experimental conditions. IGF-1 LR3 supports investigations into cellular differentiation, metabolic signaling cascades, and anabolic response pathways. These applications provide valuable insight into mechanisms associated with growth signaling networks in experimental clinical settings. <\/p>\n<hr \/>\n<h2 data-section-id=\"g6iwef\"><strong>Reconstituci\u00f3n y manipulaci\u00f3n<\/strong><\/h2>\n<p>Lyophilized IGF-1 LR3 should be reconstituted using bacteriostatic water in a sterile clinical environment. Users should apply strict aseptic technique when introducing solvent into the vial to preserve peptide integrity and experimental accuracy. Inject the solution slowly along the inner vial wall to prevent peptide destabilization. Avoid shaking the vial; instead, gently swirl until the lyophilized IGF-1 LR3 powder is fully dissolved. After reconstitution, store the solution at 2\u20138\u00b0C and maintain it in a controlled clinical environment. Proper handling procedures help preserve the stability of IGF-1 LR3 peptide for consistent experimental outcomes. <\/p>\n<hr \/>\n<h2 data-section-id=\"evp82x\"><strong>Mecanismo de acci\u00f3n<\/strong><\/h2>\n<p>IGF-1 LR3 peptide interacts primarily with insulin-like growth factor receptors involved in cellular growth and metabolic signaling. In experimental clinical settings, this interaction stimulates intracellular pathways related to protein synthesis, nutrient uptake, and cellular proliferation markers. The structural modification of IGF-1 LR3 reduces affinity for IGF-binding proteins, allowing sustained receptor activation in clinical models. In vitro studies indicate that this prolonged signaling may influence pathways related to anabolic cellular responses. Users use IGF-1 LR3 for studies to explore receptor activation dynamics and downstream molecular cascades. These mechanisms provide insight into regulatory processes associated with cellular growth and metabolic adaptation. <\/p>\n<hr \/>\n<h2 data-section-id=\"1dcajhc\"><strong>Pautas de dosificaci\u00f3n<\/strong><\/h2>\n<p> Dosing ranges reported in published experimental literature vary depending on the model system and assay design. In vitro investigations often use IGF-1 LR3 peptide concentrations measured in nanomolar to micromolar ranges depending on cell line sensitivity. Pre-clinical experimental models may adjust concentration parameters to evaluate receptor signaling responses and metabolic activity markers. Users should determine optimal concentration ranges through preliminary assay validation. Lyophilized IGF-1 LR3 should be prepared and measured carefully to maintain experimental consistency. <\/p>\n<hr \/>\n<h2 data-section-id=\"1pbh8fc\"><strong>Potential Benefits<\/strong><\/h2>\n<ul>\n<li data-section-id=\"1pm95a8\">Marcadores de respuesta celular relacionados con la se\u00f1alizaci\u00f3n del factor de crecimiento<\/li>\n<li data-section-id=\"1r9cuo2\">Observaciones de cultivo de tejidos sobre la activaci\u00f3n de v\u00edas anab\u00f3licas<\/li>\n<li data-section-id=\"1fytcje\">Estabilidad de la actividad de se\u00f1alizaci\u00f3n en entornos metab\u00f3licos simulados<\/li>\n<li data-section-id=\"1k1mv77\">Potencial de interacci\u00f3n del receptor con las v\u00edas de se\u00f1alizaci\u00f3n de IGF-1<\/li>\n<li data-section-id=\"1c1eyxc\">Marcadores de se\u00f1alizaci\u00f3n de v\u00edas angiog\u00e9nicas y proliferativas<\/li>\n<\/ul>\n<hr \/>\n<h2 data-section-id=\"1tir0k8\"><strong>Observaciones experimentales<\/strong><\/h2>\n<p>Clinical investigations involving IGF-1 LR3 peptide often observe enhanced signaling activity within IGF-1 receptor pathways in controlled experimental conditions. In vitro cell culture models demonstrate measurable changes in cellular proliferation markers and protein synthesis indicators. Users studying metabolic signaling frequently document changes in nutrient uptake pathways when IGF-1 LR3 is introduced to experimental systems. Pre-clinical models have also examined IGF-1 LR3 in relation to differentiation signaling and cellular development patterns. These observations contribute to understanding how sustained receptor activation influences complex cellular networks. IGF-1 LR3 therefore provides a reproducible framework for studying anabolic signaling pathways in experimental clinical settings. <\/p>\n<hr \/>\n<h2 data-section-id=\"1pt12ft\"><strong>Considerations<\/strong><\/h2>\n<p>Users working with IGF-1 LR3 should ensure strict clinical protocols are followed to maintain peptide stability and experimental validity. Environmental conditions such as temperature, solvent compatibility, and assay sensitivity can influence peptide behavior in vitro studies. Careful calibration of concentrations is recommended before initiating extended clinical investigation. IGF-1 LR3 peptide may interact with other growth factors or signaling molecules within complex experimental systems. Documentation of handling procedures and experimental parameters is essential for reproducibility. All work involving IGF-1 LR3 must remain within approved studies and clinical use guidelines. <\/p>\n<hr \/>\n<h2 data-section-id=\"y0g1yb\"><strong>Aviso de seguridad<\/strong><\/h2>\n<p>IGF-1 LR3 peptide should be handled using standard clinical safety practices including protective equipment and appropriate containment procedures. Users must ensure that the compound is stored, handled, and disposed of according to institutional clinical safety guidelines. Direct exposure should be minimized and clinical-grade handling tools should be used when preparing experimental solutions. This peptide is intended exclusively for scientific investigation and must not be used outside of controlled studies environments. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Users should follow all applicable regulations and institutional guidelines when handling this material. <\/p>\n<hr \/>\n<h2 data-section-id=\"1xqr4ds\"><strong>Informaci\u00f3n de almacenamiento<\/strong><\/h2>\n<p>Store lyophilized IGF-1 LR3 at \u221220\u00b0C for long-term storage to maintain peptide stability and structural integrity. For short-term clinical use, the peptide may be stored at 2\u20138\u00b0C under controlled refrigeration conditions. Protect IGF-1 LR3 from direct light exposure to prevent degradation of the peptide structure. Avoid repeated freeze-thaw cycles as these may reduce peptide stability and affect experimental reproducibility. When stored properly, IGF-1 LR3 maintains a shelf life of approximately 36 months. Proper storage ensures reliable clinical performance of lyophilized IGF-1 LR3 for studies. <\/p>\n<h2><strong>Pureza y calidad<\/strong><\/h2>\n<p>All IGF-1 LR3 vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request \u2014 message our support team after placing your order and we will forward the batch-specific COA for the vials you received. It is sold. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature. <\/p>\n<h3>\u00bfC\u00f3mo se reconstituye el IGF-1 LR3?<\/h3>\n<p>Los p\u00e9ptidos liofilizados normalmente se reconstituyen con agua bacteriost\u00e1tica o agua est\u00e9ril para inyecci\u00f3n (BWFI \/ SWFI) a una concentraci\u00f3n adecuada para la dosis planificada. A\u00f1ada el diluyente lentamente por la pared interior del vial \u2014 no inyecte el chorro directamente sobre el polvo ni agite en\u00e9rgicamente, ya que ambos procedimientos desnaturalizan el p\u00e9ptido. Gire suavemente hasta que se disuelva por completo. Los p\u00e9ptidos reconstituidos suelen almacenarse en refrigeraci\u00f3n a 2\u20138\u00b0C. <\/p>\n<h3>\u00bfC\u00f3mo debe almacenarse el IGF-1 LR3?<\/h3>\n<p>Los viales liofilizados son estables durante per\u00edodos prolongados cuando se almacenan a \u221220\u00b0C o en refrigeraci\u00f3n a 2\u20138\u00b0C, lejos de la luz directa. Despu\u00e9s de la reconstituci\u00f3n, la mayor\u00eda de los p\u00e9ptidos son estables durante 14\u201330 d\u00edas en refrigeraci\u00f3n, dependiendo del tamp\u00f3n y del p\u00e9ptido espec\u00edfico. Siempre consulte el certificado de an\u00e1lisis incluido con el vial para ver las recomendaciones de almacenamiento y los datos de estabilidad proporcionados por el proveedor. <\/p>\n<h3>What does the published literature shows?<\/h3>\n<p>The published literature on IGF-1 LR3 is summarized in our linked guide. We separate preclinical (rodent \/ cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record. <\/p>\n<h3>\u00bfEs legal pedir IGF-1 LR3 internacionalmente?<\/h3>\n<p>Peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer\u2019s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country\u2019s import rules may be detained at customs. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media del IGF-1 LR3?<\/h3>\n<p>IGF-1 LR3 has an estimated half-life of 20\u201330 hours in preclinical studies \u2014 dramatically longer than native IGF-1 (approximately 6\u20138 hours). The LR3 modification reduces IGF-binding protein (IGFBP) affinity, increasing the free (bioavailable) IGF-1 fraction in circulation and extending active duration. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia el IGF-1 LR3 del IGF-1 nativo?<\/h3>\n<p>IGF-1 LR3 is an 83-amino-acid analog of the naturally occurring 70-amino-acid IGF-1. The LR3 modification significantly reduces binding to the six known IGF-binding proteins (IGFBPs), which normally sequester ~98% of endogenous IGF-1. This results in a substantially higher free-peptide fraction and extended half-life, making IGF-1 LR3 a preferred compound in studies requiring prolonged IGF-1 receptor activation. <\/p>\n<h3>\u00bfPuedo pedir IGF-1 LR3 junto con otros p\u00e9ptidos?<\/h3>\n<p>Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are protective for the duration of standard international transit. See our peptide category page for the full stocked range and the \u201cBest Peptides for Recovery\u201d comparison guide for stacking considerations from the published literature. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Los protocolos con IGF-1 LR3 frecuentemente incluyen BPC-157 y TB-500 para soporte articular y tendinoso durante la fase anab\u00f3lica impulsada por IGF; nuestros <a href=\"\/es\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + agua bacteriost\u00e1tica)<\/a> paquetes incluyen ambos viales liofilizados con agua de reconstituci\u00f3n a $0 de costo de env\u00edo por p\u00e9ptidos.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/es\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpio sin cortisol\/prolactina<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/igf-1-lr3-peptide-guide\/\"><strong>IGF-1 LR3 \u2014 ciencia honesta, dosificaci\u00f3n y seguridad<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">946870-92-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>400<\/sub>H<sub>625<\/sub>N<sub>111<\/sub>O<sub>120<\/sub>S<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~9117.4 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Long R<sup>3<\/sup> IGF-1 (83 amino\u00e1cidos; N-terminal MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar en ~30 d\u00edas. Evitar agitaci\u00f3n vigorosa; los p\u00e9ptidos grandes se desnaturalizan al agitarlos. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorece el crecimiento celular<br \/>\n\u2705 Mejora la s\u00edntesis proteica<br \/>\n\u2705 Promueve la se\u00f1alizaci\u00f3n metab\u00f3lica<br \/>\n\u2705 Mejora la regeneraci\u00f3n tisular<br \/>\n\u2705 Boosts cellular repair<\/p>\n<p><strong>IGF-1 LR3<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70960,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5474],"class_list":["post-69022","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-igf-1-lr3","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/69022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=69022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70960"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=69022"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=69022"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=69022"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=69022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}